Associate Director, Clinical Imaging (Oncology)
Regeneron Pharmaceuticals, Inc · Warren, MI
Visit company website
FULL-TIME
Posted Nov 7, 2026
176K–287K a year
Job Description
When & Where
Our preference for this position would be to have someone on-site in our Tarrytown, NY offices 4 days per week. However, we are also open to a remote hire for an exceptional candidate.
Discover Your Role
• Create fit-for-purpose imaging biomarker strategies and work closely with research, clinical imaging and the oncology therapeutic area for the development of imaging endpoints to inform and advance the Regeneron clinical pipeline.
• Prepare and present clinical imaging strategies to senior management.
• Manage a complex network of stakeholders across Regeneron.
• Lead, design and implement multi-modality imaging measures as endpoints for oncology therapeutic clinical studies.
• Collaborate closely with Regeneron clinical teams as imaging subject matter expert to ensure optimal design and execution of imaging strategy including development of protocols, imaging manuals and charters, statistical analysis plans and clinical study reports.
• Work closely with Clinical Imaging Operations and imaging contract research organizations to ensure the flawless conduct and data integrity of studies' imaging components and endpoints.
• Serve as Study Imaging Director on clinical trials focused on qualification and utilization of novel imaging biomarkers.
• Design and implement novel PET, immuno-PET and other novel imaging agents/biomarkers in oncology clinical trials.
• Lead the interaction with regulatory agencies for communications regarding imaging endpoints and procedures.
• Lead the interaction with regulatory agencies and site ethics committees for approval of clinical imaging biomarker development studies.
This Role Requires
• PhD with a minimum of 7+ years of clinical imaging experience (minimum of 5 years within oncology drug development).
• Experience implementing central efficacy assessments using tumor response criteria such as RECIST 1.1, iRECIST, PCWG3, Lugano and IMWG in oncology clinical trials is required.
• Successful engagement experience with regulatory agencies and the ability to champion imaging innovations and lead projects effectively.
• 7+ years of imaging experience in oncology drug development and clinical PET tracer development in a pharmaceutical/biotechnology setting preferred.
• Experience as study scientific director of PET imaging biomarker clinical trials in Oncology preferred.
• Experience with radiopharmaceuticals and applying imaging as a quantitative endpoint in clinical and preclinical studies in Oncology preferred.
• Imaging CRO oversight and implementation of quality control procedures preferred.
Does this sound like you? Apply now to take your first step towards living the Regeneron Way!
Salary Range (annually)
$176,100.00 - $287,300.00
Our preference for this position would be to have someone on-site in our Tarrytown, NY offices 4 days per week. However, we are also open to a remote hire for an exceptional candidate.
Discover Your Role
• Create fit-for-purpose imaging biomarker strategies and work closely with research, clinical imaging and the oncology therapeutic area for the development of imaging endpoints to inform and advance the Regeneron clinical pipeline.
• Prepare and present clinical imaging strategies to senior management.
• Manage a complex network of stakeholders across Regeneron.
• Lead, design and implement multi-modality imaging measures as endpoints for oncology therapeutic clinical studies.
• Collaborate closely with Regeneron clinical teams as imaging subject matter expert to ensure optimal design and execution of imaging strategy including development of protocols, imaging manuals and charters, statistical analysis plans and clinical study reports.
• Work closely with Clinical Imaging Operations and imaging contract research organizations to ensure the flawless conduct and data integrity of studies' imaging components and endpoints.
• Serve as Study Imaging Director on clinical trials focused on qualification and utilization of novel imaging biomarkers.
• Design and implement novel PET, immuno-PET and other novel imaging agents/biomarkers in oncology clinical trials.
• Lead the interaction with regulatory agencies for communications regarding imaging endpoints and procedures.
• Lead the interaction with regulatory agencies and site ethics committees for approval of clinical imaging biomarker development studies.
This Role Requires
• PhD with a minimum of 7+ years of clinical imaging experience (minimum of 5 years within oncology drug development).
• Experience implementing central efficacy assessments using tumor response criteria such as RECIST 1.1, iRECIST, PCWG3, Lugano and IMWG in oncology clinical trials is required.
• Successful engagement experience with regulatory agencies and the ability to champion imaging innovations and lead projects effectively.
• 7+ years of imaging experience in oncology drug development and clinical PET tracer development in a pharmaceutical/biotechnology setting preferred.
• Experience as study scientific director of PET imaging biomarker clinical trials in Oncology preferred.
• Experience with radiopharmaceuticals and applying imaging as a quantitative endpoint in clinical and preclinical studies in Oncology preferred.
• Imaging CRO oversight and implementation of quality control procedures preferred.
Does this sound like you? Apply now to take your first step towards living the Regeneron Way!
Salary Range (annually)
$176,100.00 - $287,300.00
Additional Details
- City
- Warren
- State
- Michigan
- Country
- US
Apply and matching require a free OVN account. Browse listings anytime without signing in.